Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Cross-over Study of Closed Loop Oxygen Control in Newborn Infants Receiving Nasal Highflow Therapy Via Airvo-2 Combined With O2Matic

NCT05629910 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05629910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05629910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Cross-over Study of Closed Loop Oxygen Control in Newborn Infants Receiving Nasal Highflow Therapy Via Airvo-2 Combined With O2Matic
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2024
Completion date
July 1, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, pre-term, respiratory distress syndrome, newborn, retinopathy of prematurity